The groundbreaking rise of Viagra has consistently remained a symbol of pharmaceutical success, however its position within the broader sector now raises questions about potential returns . Copycat versions are undercutting patent protection , leading to anxieties that betting on companies heavily reliant to Viagra's once-dominant influence could b